• SPX
  • 6090.27
  • 0.25 %
  • 15.1602
  • DJI
  • 44642.52
  • -0.28 %
  • -123.1914
  • N225
  • 39091.17
  • -0.77 %
  • -304.4297
  • FTSE
  • 8308.61
  • -0.49 %
  • -40.7695
  • IXIC
  • 19859.773
  • 0.81 %
  • 159.0508
Artelo Biosciences, Inc. (ARTLW) Stock Price, News & Analysis

Artelo Biosciences, Inc. (ARTLW) Stock Price, News & Analysis

Currency in USD Disclaimer

NA

NA

NA

Day's range
$0.01
Day's range
$0.01
50-day range
$0.0051
Day's range
$0.0999
  • Country: US
  • ISIN: US04301G1287
52 wk range
$0.01
Day's range
$0.01
  • CEO: Mr. Gregory D. Gorgas M.B.A.
  • Website: Visit Site
Notice: This company has been marked as potentially delisted and may not be actively trading.


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score -4.53
  • Piotroski Score 2.00
  • Grade N/A
  • Symbol (ARTLW)
  • Company Artelo Biosciences, Inc.
  • Price $0.01
  • Changes Percentage (0%)
  • Change -$0
  • Day Low $0.01
  • Day High $0.01
  • Year High $0.01

Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. Its product candidate pipeline includes ART27.13, a synthetic dual cannabinoid G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of anorexia associated with cancer; ART12.11, a synthetic cannabidiol cocrystal for the treatment of inflammatory bowel disease and post-traumatic stress disorder (PTSD); and ART26.12, a fatty acid binding protein 5 inhibitor for treating breast and prostate cancer, neuropathic and nociceptive pain, and anxiety disorders, including PTSD. The company was formerly known as Reactive Medical, Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was incorporated in 2011 and is based in Solana Beach, California.

  • Last Earnings
  • Ex-Dividend for 5/16 Dividend
  • Dividend Payable
  • Today N/A
  • Next Earnings (Estimated) 03/30/2023
  • Fiscal Year End N/A

  • Average Stock Price Target $0.00
  • High Stock Price Target $0.00
  • Low Stock Price Target $0.00
  • Potential Upside/Downside N/A
  • Consensus Rating Neutral
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) -$1.43
  • Trailing P/E Ratio -0.01
  • Forward P/E Ratio -0.01
  • P/E Growth -0.01
  • Net Income $-9,874,000

Income Statement

Quarterly

Annual

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Artelo Biosciences, Inc. Frequently Asked Questions

  • What is the Artelo Biosciences, Inc. stock price today?

    Today's price of Artelo Biosciences, Inc. is $0.01 — it has decreased by 0% in the past 24 hours. Watch Artelo Biosciences, Inc. stock price performance more closely on the chart.

  • Does Artelo Biosciences, Inc. release reports?

    Yes, you can track Artelo Biosciences, Inc.'s financials in yearly and quarterly reports directly on Stocks.News.

  • What is the Artelo Biosciences, Inc. stock forecast?

    Watch the Artelo Biosciences, Inc. chart and read a more detailed Artelo Biosciences, Inc. stock forecast to see what analysts suggest you do with its shares.

  • What is Artelo Biosciences, Inc. stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NASDAQ, exchange stock trades by Artelo Biosciences, Inc. stock ticker.

  • How to buy Artelo Biosciences, Inc. stocks?

    Like other stocks, ARTLW shares are sold on stock exchanges such as NASDAQ. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is Artelo Biosciences, Inc.'s EBITDA?

    Artelo Biosciences, Inc. measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in Artelo Biosciences, Inc.’s financial statements.

  • What is the Artelo Biosciences, Inc.'s net income ratio for the financial year 2022?

    The net income ratio for the financial year 2022 is 0, which equates to approximately 0.00%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in Artelo Biosciences, Inc. stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including Artelo Biosciences, Inc.'s financials relevant news, and technical analysis. Artelo Biosciences, Inc.'s technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for Artelo Biosciences, Inc. stock currently indicates a “sell” signal. For more insights, review Artelo Biosciences, Inc.’s technical analysis.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.